2020 American journal of dentistry

Effectiveness of two desensitizing products: A 6-month randomized clinical, split-mouth study.

,

American journal of dentistry Vol. 33 (6) : 325-329 • Dec 2020

PURPOSE: This randomized controlled clinical trial compared the efficacy of a desensitizer containing calcium phosphate with a two-step self-etch adhesive and placebo over a 6-month period. METHODS: 50 subjects aged between 21-64 years with a sensitivity score of 6 or higher according to the Visual Analog Scale (VAS) in at least three teeth participated in this study. Teethmate Desensitizer, Clearfil SE Bond 2, and placebo (distilled water) were applied randomly to three teeth of each patient. Recall reviews were performed at baseline, 1 week, 1 month, 3 months, and 6 months after treatment, and the sensitivity scores were assessed by air-blast application. The normality of data was analyzed with Shapiro-Wilk. Since the placebo treatment was successful only in a small number of teeth, the three materials could only be compared 10 minutes after the treatment. Data were analyzed with Wilcoxon Test, Friedman and Dunn post-hoc tests (P= 0.05). RESULTS: Sensitivity decreased significantly after application for each of the three test groups when compared to the pretreatment condition (P< 0.05). There were no significant differences between the Teethmate Desensitizer and Clearfil SE Bond 2, and both materials were more effective than the placebo (P< 0.05). CLINICAL SIGNIFICANCE: Teethmate Desensitizer and Clearfil SE Bond 2 had similar desensitizing effects; both of them could be applied to treat dentin hypersensitivity for a 6-month period.

No clinical trial protocols linked to this paper

Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.
PICO Elements

No PICO elements extracted yet. Click "Extract PICO" to analyze this paper.

Paper Details
MeSH Terms
Associated Data

No associated datasets or code repositories found for this paper.

Related Papers

Related paper suggestions will be available in future updates.